{
  "drugName": "Diazepam",
  "genericName": "Diazepam",
  "brandNames": ["Valium", "Stesolid"],
  
  "searchTerms": [
    "diazepam",
    "valium",
    "seizures",
    "convulsions",
    "status epilepticus",
    "tetanus",
    "anxiety"
  ],
  
  "categories": {
    "primary": "Benzodiazepine",
    "secondary": ["Anticonvulsant", "Anxiolytic", "Muscle Relaxant"],
    "drugClass": "Benzodiazepine"
  },
  
  "bodySystems": [
    "Central Nervous System"
  ],
  
  "commonIndications": [
    "Seizures/Convulsions",
    "Status epilepticus",
    "Neonatal tetanus",
    "Anxiety disorders",
    "Panic disorders",
    "Acute agitation"
  ],
  
  "ageGroups": {
    "neonates": {
      "range": "0-28 days",
      "allowed": true,
      "cautionLevel": "high",
      "notes": "Conflicting guidelines - see indication-specific warnings",
      "specialDosing": true
    },
    "infants": {
      "range": "1-12 months",
      "allowed": true,
      "cautionLevel": "medium",
      "notes": "Standard pediatric dosing for seizures"
    },
    "toddlers": {
      "range": "1-3 years",
      "allowed": true,
      "cautionLevel": "low",
      "notes": "Standard dosing for seizures"
    },
    "preschool": {
      "range": "3-6 years",
      "allowed": true,
      "cautionLevel": "low",
      "notes": "Standard dosing"
    },
    "schoolAge": {
      "range": "6-12 years",
      "allowed": true,
      "cautionLevel": "low",
      "notes": "Standard dosing"
    },
    "adolescent": {
      "range": "12-18 years",
      "allowed": true,
      "cautionLevel": "low",
      "notes": "May use adult dosing protocols"
    }
  },
  
  "calculationType": "indication-based",
  "inputsNeeded": ["indication", "weight", "age", "route"],
  
  "indicationOptions": [
    {
      "name": "Seizures/Convulsions",
      "ageGroups": {
        "neonates": {
          "allowed": "conditional",
          "guidelineConflict": true,
          "conflictDetails": {
            "tanzania": {
              "allowed": false,
              "guideline": "Tanzania Neonatal Guideline 2019",
              "note": "Do NOT use diazepam for convulsions during neonatal period - Risk of respiratory depression"
            },
            "who": {
              "allowed": true,
              "guideline": "WHO Guidelines",
              "minAge": "2 weeks",
              "note": "Can use from 2 weeks of age"
            },
            "recommendation": "Preferred alternative: Phenobarbital. If diazepam used: ICU setting only with close monitoring. Always consult senior clinician."
          }
        },
        "infants": { "allowed": true },
        "toddlers": { "allowed": true },
        "preschool": { "allowed": true },
        "schoolAge": { "allowed": true },
        "adolescent": { "allowed": true }
      },
      "routes": [
        {
          "route": "IV",
          "preferred": true,
          "dosing": {
            "calculation": "0.3 mg/kg",
            "maxSingleDose": 10,
            "administration": "Slow IV push over 2-3 minutes",
            "repeat": "May repeat after 5-10 minutes if seizures continue",
            "maxDoses": 2,
            "frequency": "Maximum 2 doses total"
          }
        },
        {
          "route": "Rectal",
          "preferred": false,
          "indication": "If no IV access",
          "dosing": {
            "calculation": "0.5 mg/kg",
            "maxSingleDose": 10,
            "administration": "Insert rectally using syringe without needle or rectal tube",
            "repeat": "May repeat after 5-10 minutes if seizures continue",
            "maxDoses": 2,
            "frequency": "Maximum 2 doses total"
          }
        }
      ],
      "warnings": [
        "Do NOT give more than 2 doses",
        "If seizures continue after 2 doses → suspect status epilepticus",
        "Refer for advanced management if seizures persist",
        "Monitor respiratory rate closely",
        "Have resuscitation equipment ready"
      ]
    },
    {
      "name": "Neonatal Tetanus",
      "ageGroups": {
        "neonates": { "allowed": true },
        "infants": { "allowed": false, "note": "Not applicable - condition specific to neonates" },
        "toddlers": { "allowed": false, "note": "Not applicable" },
        "preschool": { "allowed": false, "note": "Not applicable" },
        "schoolAge": { "allowed": false, "note": "Not applicable" },
        "adolescent": { "allowed": false, "note": "Not applicable" }
      },
      "routes": [
        {
          "route": "IV",
          "preferred": true,
          "dosing": {
            "calculation": "0.1-0.3 mg/kg",
            "preferredDose": 0.2,
            "minDose": 0.1,
            "maxDose": 0.3,
            "administration": "Slow IV injection over 3-5 minutes",
            "frequency": "Every 1-4 hours depending on severity of spasms",
            "criticalCondition": "Respiratory rate must be ≥30/min before each dose"
          }
        },
        {
          "route": "IV Continuous Infusion",
          "preferred": false,
          "indication": "If hourly IV doses insufficient to control spasms",
          "dosing": {
            "calculation": "0.1-0.5 mg/kg/hour",
            "startDose": 0.1,
            "maxDose": 0.5,
            "totalDaily": "2.4-12 mg/kg in 24 hours",
            "administration": "Using syringe pump",
            "titration": "Start at 0.1 mg/kg/hr, increase by 0.1 mg/kg/hr if symptoms persist",
            "criticalCondition": "Respiratory rate must remain ≥30/min"
          },
          "weaning": {
            "required": true,
            "protocol": "Gradual decrease required. Switch to oral divided doses via NG tube, then wean by 10-20% daily"
          }
        }
      ],
      "warnings": [
        "⚠️ HIGH RISK of respiratory depression",
        "ICU/NICU setting ONLY",
        "Constant monitoring required: Respiratory rate, SpO2",
        "Must have ventilation bag, mask, suction at bedside",
        "Do NOT give if RR <30/min",
        "Requires weaning protocol - do NOT stop abruptly"
      ]
    },
    {
      "name": "Anxiety/Panic/Mania",
      "ageGroups": {
        "neonates": { "allowed": false, "note": "Not recommended" },
        "infants": { "allowed": false, "note": "Not recommended" },
        "toddlers": { "allowed": false, "note": "Not recommended" },
        "preschool": { 
          "allowed": "with-caution",
          "note": "Use with extreme caution. Specialist consultation required."
        },
        "schoolAge": { "allowed": true },
        "adolescent": { "allowed": true }
      },
      "routes": [
        {
          "route": "IV",
          "preferred": true,
          "indication": "Acute agitation - to calm patient",
          "dosing": {
            "adolescent": {
              "fixedDose": "5-10 mg stat"
            },
            "children": {
              "calculation": "0.1-0.2 mg/kg",
              "maxSingleDose": 10,
              "note": "Weight-based dosing safer for children"
            },
            "administration": "Slow IV push"
          }
        },
        {
          "route": "PO",
          "preferred": false,
          "indication": "Maintenance after acute stabilization",
          "dosing": {
            "calculation": "0.1 mg/kg/day",
            "frequency": "Divided doses",
            "administration": "Oral tablets"
          }
        }
      ],
      "warnings": [
        "⚠️ Long-term use should be avoided (addiction risk)",
        "Not first-line for pediatric anxiety",
        "Refer to psychiatrist/specialist for adequate management",
        "Monitor for paradoxical reactions in children",
        "Avoid in patients with respiratory problems"
      ]
    }
  ],
  
  "contraindications": [
    {
      "condition": "Severe respiratory depression",
      "severity": "absolute"
    },
    {
      "condition": "Acute narrow-angle glaucoma",
      "severity": "absolute"
    },
    {
      "condition": "Known hypersensitivity to benzodiazepines",
      "severity": "absolute"
    },
    {
      "condition": "Myasthenia gravis",
      "severity": "relative",
      "notes": "May worsen muscle weakness"
    }
  ],
  
  "generalWarnings": [
    "Risk of respiratory depression - monitor closely",
    "Have resuscitation equipment available",
    "Use with extreme caution in neonates",
    "Paradoxical reactions possible in children (agitation, aggression)",
    "Avoid abrupt discontinuation after prolonged use",
    "May impair consciousness and coordination"
  ],
  
  "formulations": [
    {
      "type": "Injection",
      "concentration": "5mg/ml",
      "ampouleSize": "2ml",
      "totalPerAmpoule": "10mg",
      "minWeight": 0.5,
      "maxWeight": null,
      "preferredFor": ["neonates", "infants", "toddlers", "preschool", "schoolAge", "adolescent"],
      "notes": "Can be used IV or rectally. For rectal: use syringe without needle."
    },
    {
      "type": "Tablet",
      "strengths": [2, 5],
      "divisible": true,
      "minWeight": null,
      "maxWeight": null,
      "preferredFor": ["schoolAge", "adolescent"],
      "excludeAgeGroups": ["neonates", "infants", "toddlers"],
      "indication": "For oral maintenance (anxiety) only, not for acute seizures",
      "notes": "For anxiety/panic maintenance treatment only"
    }
  ],
  
  "sources": [
    {
      "name": "Emergency Medicine Clinical Protocols 2nd Edition",
      "country": "Tanzania",
      "organization": "MNH | EMAT | MUHAS",
      "year": 2015
    },
    {
      "name": "Standard Treatment Guidelines and Essential Medicines List for Children and Adolescents",
      "country": "Tanzania",
      "year": 2019
    },
    {
      "name": "National Guideline for Neonatal Care and Establishment of Neonatal Care Unit",
      "country": "Tanzania",
      "year": 2019
    },
    {
      "name": "WHO Guidelines",
      "organization": "World Health Organization",
      "year": 2023
    }
  ],
  
  "lastUpdated": "2025-10-02",
  "reviewedBy": "Dr. Mariia Rukavishnikova",
  "verified": true
}
